A USPTO Docketing Change Behind the Terminal Disclaimer Collapse
Terminal disclaimers hit a 2008 low. The cause was not Cellect or Allergan but a USPTO docketing change in which applications examiners took up.
Terminal disclaimers hit a 2008 low. The cause was not Cellect or Allergan but a USPTO docketing change in which applications examiners took up.